SCHEMBL4059272

SCHEMBL4059272

CC(=O)c1cccc(S(=O)(=O)NCCN(C)C)c1

nearest known ligand 0.63

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.63
SMN1; SMN2 Q16637 1/20 0.56
TDP1 Q9NUW8 1/20 0.55
CYP2C19 P33261 1/20 0.55
LMNA P02545 2/20 0.53
PKM P14618 1/20 0.52
MAPK1 P28482 1/20 0.52
TSHR P16473 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
AKR1C3 P42330 5/20 0.51
KMT2A Q03164 2/20 0.50
MEP1B Q16820 1/20 0.50
HDAC2 Q92769 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4058118 0.92 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2TDP1CYP2C19LMNA
SCHEMBL26731607 0.89 CYP2C19 (0.70) ALDH1A1TDP1CYP2C19PKMMAPK1
SCHEMBL2850679 0.88 CYP2C19 (0.53) ALDH1A1TDP1CYP2C19PKMMAPK1
SCHEMBL26731616 0.86 CYP2C19 (0.52) ALDH1A1CYP2C19LMNAPKMMAPK1
SCHEMBL4237644 0.83 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2CYP2C19PKMMAPK1
SCHEMBL4237642 0.83 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2CYP2C19PKMMAPK1
SCHEMBL14973141 0.83 MEP1B (0.50) ALDH1A1CYP2C19PKMMAPK1TSHR
SCHEMBL11539772 0.82 TSHR (0.65) ALDH1A1SMN1; SMN2LMNAPKMMAPK1
SCHEMBL2560714 0.82 ALDH1A1 (0.72) ALDH1A1SMN1; SMN2TDP1CYP2C19LMNA
SCHEMBL4233646 0.82 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2TDP1CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009111260-A1 PHENYLSULFONAMIDE-SUBSTITUTED, PYRAZOLO[1, 5-A]PYRIMIDINES, METHODS FOR PREPARATION AND USES THEREOF WYETH (US) 2009-09-11 WO disclosed